Role of Intraventricular Sodium Nitroprusside in Vasospasm Secondary to Aneurysmal Subarachnoid Haemorrhage: A 5-year Prospective Study with Review of the Literature

Abstract

Objective: Cerebral vasospasm remains an important cause of permanent neurological injury and death following aneurysmal subarachnoid haemorrhage, despite the best current medical therapy. Sodium nitroprusside was recently suggested as a treatment option for cerebral ischaemia in patients with severe medically refractive vasospasm after subarachnoid haemorrhage.

Methods: Twenty patients of aneurysmal SAH with severe vasospasm, corroborated on transcranial Doppler (TCD), were included in this prospective study. The neurological condition of all patients was classified as Hess and Hunt grade II or higher. The diagnosis of severe delayed cerebral vasospasm refractory to conventional treatment (HHH therapy and nimodipine) was established before treatment. Ten patients received intraventricular sodium nitroprusside (SNP), while the other 10 had either major systemic illness or did not consent, formed the control group of the study. SNP was instilled in escalating doses with a starting dose of 4 mg/mL and reversal of vasospasm was monitored on neurological examination along with TCD in a basic ICU setting without the need for neurophysiological or invasive monitoring.

Results: All patients in the study group showed an improvement in TCD velocities post-SNP instillation. Adverse effects were vomiting and hypotension in the SNP group which responded to medical management. The overall neurological outcome was good or excellent in 7/10 patients in the SNP group. Comparison between the two groups revealed improvement in TCD velocities and GCS in the SNP group thus affecting the long-term prognosis.

Conclusion: Intraventricular sodium nitroprusside represents a promising method of treatment for established delayed cerebral vasospasm and cerebral ischaemia refractory to conventional treatment.

Key words

delayed cerebral vasospasm - subarachnoid hemorrhage - intraventricular sodium nitroprusside

References

• 1 Lee KH, Lukovits T, Friedman JA. “Triple-H” therapy for cerebral vasospasm following subarachnoid hemorrhage.  Neurocrit Care. 2006;  4 68-76
• 2 Wu CT, Wong CS, Yeh CC. Treatment of cerebral vasospasm after subarachnoid hemorrhage – a review.  Acta Anesthesiol Taiwan. 2004;  42 215-222
• 3 Egge A, Waterloo K, Sjoholm H. et al . Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clincal, prospective, randomized, controlled study.  Neurosurgery. 2001;  49 593-605
• 4 Sakowitz OW, Unterberg AW. Detecting and treating microvascular ischemia after subarachnoid hemorrhage.  Curr Opin Crit care. 2006;  12 103-111
• 5 Shatalov VI, Shchegolev AV. Effect of infusion therapy on central hemodynamics and the outcome of treatment in patients with subarachnoidal hemorrhage.  Anesteziol Reanimatol. 2005;  4 55-58
• 6 Wink DA, Cook JA, Pacelli R. The effect of various nitric oxide donor agents on hydrogen peroxide mediated toxicity, direct correlation between nitric oxide formation and protection.  Arch Biochem Biophysics. 1996;  331 241-248
• 7 Frank M, Faraci FM, Brian Jr JE. Nitric oxide and cerebral circulation.  Stroke. 1994;  25 692-703
• 8 Thomas JE, Rosenwasser RH. Reversal of severe cerebral vasospasm in three patients after aneurysmal subarachnoid hemorrhage: initial observations regarding the use of intraventricular sodium nitroprusside in humans.  Neurosurgery. 1999;  44 48-57
• 9 Thomas JE, Rosenwasser RH, Armonda R. et al . Safety of intra-thecal sodium nitroprusside for the treatment and prevention of refractory cerebral vasospasm and ischemia in humans.  Stroke. 1999;  1409-1416
• 10 Thomas J, MacGinnis G. Safety of Intraventricular sodium nitroprusside and thiosulfate for the treatment of cerebral vasospasm in the intensive care unit setting.  Stroke. 2002;  33 486-492
• 11 Thomas JE. Molecular biological considerations in cerebral vasospasm following aneurysmal subarachnoid hemorrhage.  Neurosurg Focus. 1997;  3 1-5
• 12 Thomas JE, Nemirovsky A, Zelman V. et al . Rapid reversal of endothelin-1-induced cerebral vasoconstriction by intrathecal administration of nitric oxide donors.  Neurosurgery. 1997;  40 1245-1249
• 13 Thomas JE, Armonda RA, Rosenwasser RH. Reversal of severe cerebral vasospasm in a patient following aneurysmal subarachnoid hemorrhage: preliminary observations on the use of intrathecal nitric oxide donors in humans.  J Neurosurg. 1998;  88 198
• 14 Vajkoczy P, Hubner U, Horn P. et al . Intrathecal sodium nitroprusside improves cerebral blood flow and oxygenation in refractory cerebral vasospasm and ischemia in humans.  Stroke. 2000;  5 1195-1197
• 15 Rothberg CS, Weir B, Overton TR. Treatment of subarachnoid hemorrhage with sodium nitroprusside and phenylephrine; an experimental study.  Neurosurgery. 1979;  5 588-595
• 16 Raabe A, Zimmermann M, Setzer M. et al . Effect of intraventricular sodium nitroprusside on cerebral hemodynamics and oxygenation in poor-grade aneurysm patients with severe, medically refractory vasospasm.  Neurosurgery. 2002;  1006-1014
• 17 Kumar R, Pathak A, Mathuriya SN. et al . Intraventricular sodium nitroprusside therapy; a future promise for refractory subarachnoid haemorrhage-induced vasospasm.  Neurol India. 2003;  51 197-202
• 18 Pathak A, Mathuria SN, Khandelwal N. et al . Intermittent low dose intrathecal sodium nitroprusside therapy for treatment of symptomatic aneurysmal SAH-induced vasospasm.  Br J Neurosurg. 2003;  17 306-310
• 19 Pachl J, Haninec P, Tencer T. et al . The effect of subarachnoid sodium nitroprusside on the prevention of vasospasm in subarachnoid haemorrhage.  Acta Neurochir Suppl. 2005;  95 141-145
• 20 Januja N, Mayser SA. Cerebral vasospasm after subarachnoid hemorrhage.  Curr Opin Crit care. 2003;  9 113-119
• 21 Vajkoczy P, Horn P, Thome C. et al . Regional cerebral blood flow monitoring in the diagnosis of delayed ischemia following aneurysmal subarachnoid hemorrhage.  J Neurosurg. 2003;  98 1227-1234
• 22 Aaslid R, Huber P, Normes H. Transcranial Doppler method in the evaluation of cerebrovascular spasm.  Neuroradiology. 1988;  28 11-16
• 23 Lindegaard KF, Bakke SJ, Sorteberg W. et al . A non-invasive Doppler ultrasound method for the evaluation of patients with subarachnoid hemorrhage.  Acta Radiol. 1986;  369 96-98
• 24 Dorsch NW. Therapeutic approaches to vasospasm in subarachnoid hemorrhage.  Curr Opin Crit care. 2002;  8 128-133
• 25 Afshar JKB, Pluta RM, Block RJ. et al . Effect of intracarotid nitric oxide on primate cerebral vasospasm after subarachnoid hemorrhage.  J Neurosurg. 1995;  83 118-122
• 26 Wolf WE, Banerjee A, Jill BS. et al . Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor.  J Neurosurg. 1998;  89 279-288
• 27 Heros RC, Zervas NT, Lavyne MH. et al . Reversal of experimental cerebral vasospasm by intravenous nitroprusside therapy.  Surg Neurol. 1976;  6 227-229
• 28 Hirsh LF. Intra-arterial nitroprusside treatment of acute experimental vasospasm.  Stroke. 1980;  11 601-605
• 29 Akerman M, de-Pommery AG. Experimental study of the cerbrovascular effects of SNP in the baboon Papio.  Neuro Chirurgie. 1976;  22 43-57
• 30 Levy WJ, Bay JW. Aminophylline plus nitroprusside and dopamine for treatment of cerebral vasospasm.  J Neurosurgery. 1982;  56 646-649
• 31 Egemen N, Turker RK, Sanlidilek U. et al . The effect of intrathecal sodium nitroprusside on severe chronic vasospasm.  Neurol Res. 1993;  15 310-315
• 32 Marshman LA, Morice AH, Thompson JS. Increased efficacy of sodium nitroprusside in middle cerebral arteries following acute subarachnoid hemorrhage: indications for its use after rupture.  J Neurosurg Anesthesiol. 1998;  10 171-177

Correspondence